Vera Therapeutics (VERA) Free Cash Flow Growth (3y) (2023 - 2026)
Vera Therapeutics (VERA) Free Cash Flow Growth (3y) (2023 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
24.91% |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
20.11% |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
14.71% |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
Vera Therapeutics |
2.45 Bn |
1.85 Bn |
- |
-59.42% |
| Date | Value |
|---|
| Mar 31, 2026 |
-59.42% |
| Dec 31, 2025 |
-49.07% |
| Sep 30, 2025 |
-49.79% |
| Jun 30, 2025 |
-42.43% |
| Mar 31, 2025 |
-82.38% |
| Dec 31, 2024 |
-83.57% |
| Sep 30, 2024 |
-89.17% |
| Jun 30, 2024 |
-48.04% |
| Mar 31, 2024 |
-101.73% |
| Dec 31, 2023 |
2.72% |
| Sep 30, 2023 |
-110.96% |
| Jun 30, 2023 |
-86.90% |
| Mar 31, 2023 |
-123.44% |
